Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
| Summary of Significant Accounting Policies (Narrative) Details | ||
| Amortization of deferred financing costs | $ 28,116 | $ 0 |
| Research and development costs | 309,000 | 313,000 |
| Stock based compensation expense | 19,891 | 14,359 |
| Potentially dilutive securities | ||
| Common shares from convertible debentures and related accrued interest | 153,239,914 | 84,319,934 |
| Common shares from outstanding warrants | 33,571,901 | 15,780,818 |
| Advertising costs | 0 | $ 0 |
| Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation ("FDIC") limit. | $ 250,000 | |
| X | ||||||||||
- Definition Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations. No definition available.
|
| X | ||||||||||
- Definition Common shares from convertible debentures and related accrued interest No definition available.
|
| X | ||||||||||
- Definition Common shares from convertible debentures and related accrued interest No definition available.
|
| X | ||||||||||
- Definition ConcentrationsOfCreditRiskAbstract No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. No definition available.
|
| X | ||||||||||
- Definition Company raised net proceeds from from the issuance of convertible debt No definition available.
|
| X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|